[Intra- and extracellular electrolyte concentration of estrogen therapy on patients with carcinoma of the prostate (author's transl)].
D000136:Acid-Base Equilibrium; D000328:Adult; D000367:Age Factors; D000368:Aged; D001798:Blood Proteins / Q000032:analysis; D004912:Erythrocytes / Q000032:analysis; D004967:Estrogens / Q000009:adverse effects* / Q000494:pharmacology / Q000627:therapeutic use; D005110:Extracellular Space; D006400:Hematocrit; D006452:Hemoglobinometry; D006801:Humans; D008297:Male; D008875:Middle Aged; D011188:Potassium / Q000032:analysis / Q000097:blood / Q000378:metabolism*; D011471:Prostatic Neoplasms / Q000188:drug therapy* / Q000378:metabolism; D012964:Sodium / Q000032:analysis / Q000097:blood / Q000378:metabolism*; D014882:Water-Electrolyte Balance
D001798:Blood Proteins; D004967:Estrogens; D012964:Sodium; D011188:Potassium
Intra- und extracelluläre Elektrolykonzentration unter Oestrogen-Therapie bei Prostatacarcinom-Patienten.